Krystal Biotech (KRYS) PT Nearly Doubled to $67 at Cantor Fitzgerald
Tweet Send to a Friend
Cantor Fitzgerald analyst Elemer Piros raised the price target on Krystal Biotech (NASDAQ: KRYS) to $67.00 (from $34.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
